Remove 2016 Remove Aneurysm Remove Strokes
article thumbnail

Abstract TP74: Trends in extracranial-intracranial bypass procedure from 2016-2019

Stroke Journal

Stroke, Volume 56, Issue Suppl_1 , Page ATP74-ATP74, February 1, 2025. Trends in ECIC-Bypass utilization, demographic and hospital characteristics, and unfavorable outcome were evaluated for each condition.Results:From 2016 to 2019, total number of EC-IC procedures increased significantly by 43% from 740 to 1060 weighted cases.

article thumbnail

Abstract TP5: Impact of Race on Outcomes in the Endovascular and Microsurgical Treatment in Patients With Intracranial Aneurysms: Analysis of the Stroke Thrombectomy and Aneurysm Registry

Stroke Journal

Stroke, Volume 55, Issue Suppl_1 , Page ATP5-ATP5, February 1, 2024. Introduction:Impact of race on outcomes in the treatment of intracranial aneurysm (IA) remains unclear. The primary outcome was 90-day mRS 0-2.

article thumbnail

Abstract TMP1: Identification of True Biomarkers for Unruptured Cerebral Aneurysms through Revisiting Cerebral Aneurysm Transcriptomes

Stroke Journal

Stroke, Volume 56, Issue Suppl_1 , Page ATMP1-ATMP1, February 1, 2025. A cerebral aneurysm (CA) is an abnormal artery deformation in the brain that may lead to hemorrhagic stroke, brain damage, coma, and even death when a CA ruptures. We hypothesized that increasing CA sample size will allow more robust biomarker identification.

article thumbnail

Abstract 184: Comparing Characteristics and Outcomes of Ruptured and Unruptured Mycotic Aneurysms: A Single Center Study

Stroke: Vascular and Interventional Neurology

Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. IntroductionInfectious intracranial aneurysms (IIAs), commonly referred to as mycotic aneurysms, are a common sequela of infective endocarditis (IE). The median (IQR) age of our population was 45 (27‐65) years, with 28/41 (68.3%) male patients.

article thumbnail

Abstract 175: Impact of COVID?19 on Intracranial Aneurysm Treatment and Outcomes: A Nationwide Propensity Score Matched Study.

Stroke: Vascular and Interventional Neurology

Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. There is limited data on the influence of COVID‐19 on treatment and outcomes in patients with intracranial aneurysms. From 2016 to 2020, an upward trend in hospitalizations for ischemic stroke was seen among patients treated for IAs (6.1%

article thumbnail

Abstract 182: Optimal Timeframe from Securing Mycotic Aneurysms to Cardiac Surgery: A Single Center Study

Stroke: Vascular and Interventional Neurology

Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. IntroductionInfectious Intracranial Aneurysms (IIAs), commonly referred to as mycotic aneurysms, are a common sequela of infective endocarditis (IE). The median (IQR) age of our population was 45 (27‐65) years, with 28/41 (68.3%) male patients.

article thumbnail

Abstract 183: Characteristics and Outcomes of Treated and Untreated Mycotic Aneurysms: A Single Center Study

Stroke: Vascular and Interventional Neurology

Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. IntroductionInfectious intracranial aneurysms (IIAs), commonly referred to as mycotic aneurysms, are a common sequela of infective endocarditis (IE). The morbidity rate is known to be about 80% in ruptured IIAs.